Modulation of immunity and ceacam1 activity
OwnerGal Markelinventor
Life of this patent
Estimating the term…
Abstract
The present technology comprises methods for regulating an the immune system, and in particular methods for the regulation of a specific immune response, including the regulation of lymphocyte activity. Methods of the present technology comprise both the negative and positive modulation of CEACAM1 protein function.
Claims13
1-22. (canceled)
A method for diagnosing a cancer in a human patient, said method comprising the step of contacting a biological sample derived from said patient with a CEACAM1 binding agent conjugated to a detectable moiety.
A method for diagnosing a cancer in a human patient, wherein said method comprises the step of injecting into said patient a CEACAM1 binding agent conjugated to a detectable moiety.
34-52. (canceled)
Dependencies are inferred from the claim text.